RNS25 Aug 2021 08:06
RNS Number : 6656J
ValiRx PLC
25 August 2021
25 August 20 21
ValiRx Plc
( " ValiRx" or the " Company ")
Appointment of Broker
ValiRx Plc (AIM: VAL), has appointed Cenkos Securities plc ("Cenkos") as its sole broker with immediate effect.
In connection with the appointment of Cenkos, the Company has granted Cenkos with a warrant over 3,902,949 ordinary shares in the Company exercisable at price of 22p, being the closing mid-price on 24 August 2021 ("Warrants"). The Warrants are exercisable in whole or in part for the period commencing 12 months after the commencement of their engagement and ending 60 months after their engagement.
Dr Kevin Cox, Chairman commented: "We are very much looking forward to working closely with the Cenkos growth companies team to help deliver and further develop the strategy we have been building over the last year. After a period of consolidation and stability, this is a natural evolution in our growth plans."
ValiRx plc